Taking people in FranceNo phase
Registry of treatment and follow-up for non-muscle-invasive bladder cancer
Records how adults with non-muscle-invasive bladder cancer are treated and followed up.
Key facts
- Who runs it
- Association Francaise d'Urologie
- Where
- Aix-en-Provence, Angers, Arras, Aubergenville, Beauvais, Caen, Cesson-Sévigné, Cornebarrieu, Eaubonne, La Roche-sur-Yon, Le Kremlin-Bicêtre, Le Mans, Le Puy-en-Velay, Levallois-Perret, Lorient, Lyon, Mantes-la-Jolie, Marseille, Martigues, Meaux, Montpellier, Nîmes, Paris, Perpignan, Pontoise, Pringy, Quint-Fonsegrives, Rouen, Royan, Saint-Germain-en-Laye, Saint-Grégoire, Saint-Herblain, Saint-Jean, Saint-Nazaire, Saintes, Suresnes, Tarbes, and Toulouse, FranceSee the 44 sites
- Trial code
- Registry title
- AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
- Status
- Recruiting
- People taking part
- 8,000 people, planned
- Started
- 21 Feb 2023
- Expected to end
- Feb 2035
- Type of study
- Observational
- Record updated
- 30 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are being followed for a bladder tumor that has not grown into the muscle wall. They must have had a urine test (biomarker) before the tumor was removed and examined.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Non-muscle-invasive bladder tumor (a bladder tumor that has not grown into the muscle wall)
- Earlier treatment
- Must have had a urine test (biomarker) before the tumor was removed (resection, biopsy) for diagnosis or recurrence
- Biomarker or test result
- A urine test (biomarker) result before tumor removal is asked for; no specific result is named
Main reasons for not taking part
- Bladder tumor that is not urothelial
- Patient refuses follow-up
- Patient opposes taking part in the study
- Adult protected by law
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patient being monitored for a non-muscle-invasive bladder tumor and having undergone a urinary test (biomarker) prior to their resection (biopsy) diagnosis or recurrence,
- AND adult (equal to or > 18 years old),
- AND affiliated with a social security scheme in France,
- AND whose monitoring will be carried out at the recruiting center
Who cannot take part
- Patient being monitored for a non-urothelial bladder tumor
- Patient refusing follow-up
- Opposition to participation in the study
- Adult protected by law
Where in France
- Hopital Prive de ProvenceAix-en-Provence, FranceContact: Arnaud MONGES, MDTaking people
- CHU AngersAngers, FranceContact: Pierre Bigot, MD, PhDTaking people
- Hôpital Privé Arras Les BonnettesArras, FranceContact: Frederic BOUTEMY, MDTaking people
- Centre hospitalier Privé MontgradéAubergenville, FranceContact: Elia YOUNES, MDTaking people
- Centre Hospitalier Beauvais Simone VeilBeauvais, FranceContact: Luu Le VanTaking people
- CHU CaenCaen, FranceContact: Romain LefrancTaking people
- Hôpital Privé de SévignéCesson-Sévigné, FranceContact: Philippe GuiraudTaking people
- Clinique des CèdresCornebarrieu, FranceContact: Olivier Merigot de TreignyTaking people
- GH Eaubonne-Montmorency Hopital Simone VeilEaubonne, FranceContact: Alaa ABDELWAHAB, MDTaking people
- CHD VendéeLa Roche-sur-Yon, FranceContact: Constance Deboudt-MacéTaking people
- CHU Kremlin Bicêtre APHPLe Kremlin-Bicêtre, FranceContact: Cedric LebacleTaking people
- Pôle Santé SudLe Mans, FranceContact: Maximilien BARON, MDTaking people
- Clinique Bon SecoursLe Puy-en-Velay, FranceContact: Marlene GuandalinoTaking people
- Hôpital Franco-Britannique Cognac JayLevallois-Perret, FranceContact: Caroline PettenatiTaking people
- Clinique Mutualiste de la porte de l'OrientLorient, FranceContact: Louis Sauty, MDTaking people
- Clinique de La SauvegardeLyon, FranceContact: Emmanuel DeligneTaking people
- Hôpital Edouard HeriotLyon, FranceContact: Marc ColombelTaking people
- Hopital Lyon SudLyon, FranceContact: Alain RuffionTaking people
- Clinique de la Région MantaiseMantes-la-Jolie, FranceContact: Medhi ArianeTaking people
- Hôpital privé Européen - MarseilleMarseille, FranceContact: Julien DeturmenyTaking people
- Centre Hospitalier MartiguesMartigues, FranceContact: Harry ToledanoTaking people
- Grand Hopital de l'Est FrancilienMeaux, FranceContact: Julien SarkisTaking people
- Clinique Beau SoleilMontpellier, FranceContact: Gregoire PoinasTaking people
- CHU NîmesNîmes, FranceContact: Stephane DroupyTaking people
- CH Saint-Louis APHPParis, FranceContact: Alexandra Masson-Lecomte, MD, PhDTaking people
- GH Paris Saint-JosephParis, FranceContact: Constance MICHEL, MDTaking people
- Gh Pitie Salpetriere AphpParis, FranceContact: Morgan RoupretTaking people
- Hôpital Européen Georges Pompidou APHPParis, FranceContact: Francois AUDENET, MD, PhDTaking people
- Ch PerpignanPerpignan, FranceContact: Tarek DJELOUAT, MDTaking people
- GHT Novo - CH René Dubos PontoisePontoise, FranceContact: Stéphane BartTaking people
- Centre Hospitalier Annecy GenevoisPringy, FranceContact: Olivier SkowronTaking people
- Clinique La Croix Du SudQuint-Fonsegrives, FranceContact: Benjamin PradereTaking people
- Clinique MathildeRouen, FranceContact: Blandine TamarelleTaking people
- Clinique Saint-HilaireRouen, FranceContact: Benoit MalvalTaking people
- Clinique PasteurRoyan, FranceContact: Priscilla LeonTaking people
- Clinique Saint Germain en layeSaint-Germain-en-Laye, FranceContact: Dimitri GambachidzeTaking people
- Hopital Privé Saint GrégoireSaint-Grégoire, FranceContact: Edouard TARIEL, MDTaking people
- Clinique Santé AtlantiqueSaint-Herblain, FranceContact: Quentin-Côme LE CLERC, MDTaking people
- Clinique de l'UnionSaint-Jean, FranceContact: Raphael BenhaimTaking people
- Polyclinique de l'EuropeSaint-Nazaire, FranceContact: Louis Marconnet, MDTaking people
- Centre Hospitalier de SaintongeSaintes, FranceContact: Guillaume Hugues, MDTaking people
- Hopital FochSuresnes, FranceContact: Yann NeuzilletTaking people
- Polyclinique de l'OrmeauTarbes, FranceContact: Guillaume NORMAND, MDTaking people
- Clinique PasteurToulouse, FranceContact: Julien GUILLOTREAU, MDTaking people
About the trial
What the trial wants to find out
The AFU has set itself the task of setting up a register of medical practices in order to define possible improvements in the therapeutic management and follow-up of NMIBC. In order to obtain representative data, all urologists who are members of the AFU may be invited to include their patients.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- AFU Registry of the Therapeutic Management and Follow-up of Non-Muscle-Invasive Bladder Cancer
- Plain-language title
- Registry of treatment and follow-up for non-muscle-invasive bladder cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 30 April 2026